Clinical Scorecard: A Phased Strategy for Managing Chronic Mesh Infections After Hernia Surgery: Insights from a Single-Center Study

At a Glance

Key Highlights

• Chronic mesh infection defined as symptoms persisting or arising at least 3 months post mesh repair surgery.
• Majority of mesh infections occurred after open ventral hernia repairs using polypropylene mesh.
• Staged surgical approach with mesh explantation (complete or partial) is the predominant management strategy.

Guideline-Based Recommendations

Diagnosis

• Identify chronic mesh infection by clinical symptoms such as pus discharge, pain, swelling lasting ≥3 months post-surgery.
• Use microbiological cultures including gram stain and mycobacterial assays to guide diagnosis.
• Consider biopsy for inflammatory granulation tissue in suspected non-tuberculous mycobacterial infections.

Management

• Employ a staged surgical approach involving mesh explantation followed by delayed hernia repair.
• Complete mesh explantation preferred when feasible; partial explantation may be considered.
• Single-stage mesh repair is rarely performed and reserved for select cases.
• Surgical wound may be closed with suction drains or allowed to heal by secondary intention.
• Medical treatment for non-tuberculous mycobacterial infections when indicated.

Monitoring & Follow-up

• Follow patients post-explantation for wound healing, typically averaging 6.7 weeks.
• Assess for symptomatic hernia recurrence clinically; routine imaging not routinely performed in asymptomatic patients.

Risks

• Risk of enterocutaneous fistulas in chronic mesh infections (~28% incidence).
• Potential for hernia recurrence following mesh explantation and staged repair.
• Surgical site complications such as seroma or hematoma were not documented in this cohort.

Patient & Prescribing Data

64 patients with chronic mesh infections after inguinal or ventral hernia repair, predominantly male, mean age 46.5 years, mostly elective primary hernia repairs.

Majority underwent staged mesh explantation with open surgical approach; laparoscopic explantation not performed. Medical therapy used selectively for mycobacterial infections.

Clinical Best Practices

• Define chronic mesh infection as symptoms persisting beyond 3 months post-repair to differentiate from early surgical site infections.
• Utilize staged surgical management with mesh explantation to optimize infection control and facilitate later hernia repair.
• Perform thorough microbiological evaluation including cultures and mycobacterial testing to guide adjunctive medical therapy.
• Close surgical wounds with drains or allow secondary intention healing to reduce complications.
• Refer complex mesh infections to specialized tertiary centers for multidisciplinary management.

References

• Mesh infection rates and hernia repair outcomes
• Enterocutaneous fistula incidence in mesh infections